FDA Approves Bristol-Myers Squibb Late-Stage Breast Cancer Drug Ixempra
Oct 20th 2007Drug InformationBreast Cancer
An FDA spokesperson on Tuesday said the agency approved Bristol-Myers Squibb’s chemotherapy drug Ixempra for use as a breast cancer treatment for women who have not responded to other treatments, as well as for use in combination with [click link for full article]
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
